NCT06672679

Brief Summary

In this trial, we will be pilot-testing a family-based dating violence prevention program for Latine caregivers and adolescents. Participants will be randomized 1:1 to receive a community-based 6 week intervention or to a wait-list control where they will receive a resource guide.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 4, 2024

Completed
27 days until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

January 21, 2026

Status Verified

February 1, 2025

Enrollment Period

8 months

First QC Date

October 30, 2024

Last Update Submit

January 20, 2026

Conditions

Keywords

dating violence preventionculturally affirming preventioncaregiver-adolescent interventionHispanic and Latino

Outcome Measures

Primary Outcomes (2)

  • Acceptability

    Acceptability Intervention Measure (scored on a Likert scale, 1 to 5 with 1 being completely disagree and 5 being completely agree). 4 items will be averaged for a summary score with higher numbers meaning higher acceptability.

    weekly for 6 weeks, after each intervention session

  • Feasibility

    %participants who are enrolled, %consented, % randomized, % completed baseline, follow up and 3 month follow up surveys

    baseline (pre-intervention), 1 week post-intervention follow up, 3 month post-intervention follow up surveys

Secondary Outcomes (7)

  • Self-efficacy in preventing dating violence

    baseline (pre-intervention), 1 week post-intervention follow up, 3 month post-intervention follow up surveys

  • Motivation to preventing dating violence

    baseline (pre-intervention), 1-week post intervention follow up, 3 month post-intervention follow up surveys

  • Attitudes around dating violence

    baseline (pre-intervention), 1-week post intervention follow up, 3 month post-intervention follow up surveys

  • Caregiver-adolescent communication around dating violence

    baseline (pre-intervention), 1-week post intervention follow up, 3 month post-intervention follow up surveys

  • Parental monitoring

    baseline (pre-intervention), 1-week post intervention follow up, 3 month post-intervention follow up surveys

  • +2 more secondary outcomes

Other Outcomes (3)

  • Ethnic Identity

    baseline (pre-intervention), 1-week post intervention follow up, 3 month post-intervention follow up surveys

  • Acculturation conflict measure

    baseline (pre-intervention), 1-week post intervention follow up, 3 month post-intervention follow up surveys

  • Discrimination Scale

    baseline (pre-intervention), 1-week post intervention follow up, 3 month post-intervention follow up surveys

Study Arms (2)

Juntos intervention

EXPERIMENTAL

In the Juntos intervention, 24 caregiver-adolescent dyads will receive a 6 week family-based dating violence prevention intervention called Juntos. Juntos includes 6 in-person sessions and 5 at home activities and was developed by Latino caregiver-adolescent dyads. Topics include cultural values and practices, talking about dating and dating violence, rule-setting, understanding signs of healthy and unhealthy relationships, and resources for support.

Behavioral: Juntos

Control group

ACTIVE COMPARATOR

The control arm will resource a resource guide and can be placed on a wait list to receive the intervention after the intervention is complete

Behavioral: Resource guide

Interventions

JuntosBEHAVIORAL

6 week family-based intervention

Juntos intervention
Resource guideBEHAVIORAL

Active control arm will receive a resource guide

Control group

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Adolescents
  • Between the ages of 12-16
  • Identify as Hispanic or Latino/a/x/e
  • Speaks Spanish or English
  • Lives within 50 miles of Pittsburgh, Pennsylvania
  • Has a participating parent or caregiver\* in the study
  • Adults
  • Over the age of 18
  • Identifies as Hispanic or Latino/a/x/e
  • Speaks Spanish
  • Lives within 50 miles of Pittsburgh, Pennsylvania
  • Is a caregiver of a participating adolescent in the study
  • Was born outside of the United States

You may not qualify if:

  • Unable to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Primary Care Center

Pittsburgh, Pennsylvania, 15213, United States

Location

Casa San Jose

Pittsburgh, Pennsylvania, 15216, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: We are using 3:1 recruitment (for every 3 intervention dyads, 1 control dyad) to ensure optimal investment in intervention group for this pilot trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 30, 2024

First Posted

November 4, 2024

Study Start

December 1, 2024

Primary Completion

August 1, 2025

Study Completion

September 1, 2025

Last Updated

January 21, 2026

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Due to the sensitivity of the survey data, we will not share individual patient data

Locations